Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3351 results

Sort By:

Effects of tES Combined With CMDT Gait Training on Cognition, Cortical Activity, Spinal Motoneuron Excitability and Motor Performance in Stroke Individuals

Study ID: NCT07236216
Start Date: 2025-12-20
End Date: 2027-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

High-definition transcranial direct current stimulation (Active)

High-definition transcranial alternating stimulation (Active)

High-definition transcranial electrical stimulation (sham)

Cognitive-motor dual task gait training

Conventional Physical therapy

Sponsor

Mahidol University

Source: clinicaltrials.gov

Share:
Add to list

Impact of Epilepsy on the Brainstem Adenosine Pathway and Its Relation With Arousal and Respiratory Reactivity

Study ID: NCT07249034
Start Date: 2026-01-01
End Date: 2028-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

1 Hypercapnic challenge while participant is awake

PET/MRI acquisition

Sponsor

Civil Hospices of Lyon

Source: clinicaltrials.gov

Share:
Add to list

Lifestyle Behavioural Intervention on Breast Cancer Survivors for the Treatment of Overweight/Obesity.

Study ID: NCT06577545
Start Date: 2026-01
End Date: 2026-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

92

Intervention / Treatment

Behavioural Lifestyle (BL)

Sponsor

University of Thessaly

Source: clinicaltrials.gov

Share:
Add to list

Post-surgical Delirium in Patients Undergoing Radical Cystectomy.

Study ID: NCT03806439
Start Date: 2028-11-25
End Date: 2029-11-24
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Radical cystectomy.

Sponsor

University of Alexandria

Source: clinicaltrials.gov

Share:
Add to list

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

Study ID: NCT07235293
Start Date: 2026-01-20
End Date: 2027-04-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

DSP107 + Atezolizumab

Fruquintinib

Sponsor

Kahr Bio Australia Pty Ltd

Source: clinicaltrials.gov

Share:
Add to list

Impact of PharmaTE Trial on Glycemic Control, Diabetes Knowledge, Medication Adherence and Quality of Life in Type 2 Diabetes Patients: A Mixed-Method Study Protocol

Study ID: NCT07043816
Start Date: 2025-12-30
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

154

Intervention / Treatment

PharmaTE Trial

Sponsor

Rabia Hussain

Source: clinicaltrials.gov

Share:
Add to list

Mitigating Racial Disparities in Shared Decision Making in the Intensive Care Unit

Study ID: NCT05710744
Start Date: 2026-03-02
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

106

Intervention / Treatment

Shared decision making tip sheet

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

A Phase II RCT Trial of Betaine vs. Placebo for Serologically Diagnosed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Study ID: NCT07276204
Start Date: 2026-03-31
End Date: 2035-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

70

Intervention / Treatment

Betaine

Placebo

Sponsor

Southern California Institute for Research and Education

Source: clinicaltrials.gov

Share:
Add to list

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

Study ID: NCT06948084
Start Date: 2026-01-29
End Date: 2026-02-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Biospecimen Collection

Bone Marrow Biopsy

Carfilzomib

Computed Tomography

Daratumumab and Recombinant Human Hyaluronidase

Dexamethasone

FDG-Positron Emission Tomography

Pomalidomide

Teclistamab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD

Study ID: NCT05170048
Start Date: 2026-06
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

EG-301

AREDS2 supplements

Sponsor

Evergreen Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list